Research - Page 4 of 10 - Fideres

US: Class Actions: How Arbitration Clauses Are Reshaping the Landscape

Firms increasingly use arbitration clauses to limit consumers' ability to pursue collective actions, foreclosing an important mechanism for remedy in

September 27, 2022

FedEx And UPS Under Fire: Delivery Duopoly Examined

Every year, for the past 8 years, FedEx and UPS have announced identical or nearly identical general rate increases that

Option Damages In US Security Fraud Allegations

Previously, Fideres looked into how publicly traded options have become an essential feature in many securities fraud cases. Currently, damages

Paying For Knowledge: The Rising Cost Of Academic Journals

The academic journal publishing market was worth $4.3 bn in the US in 2019. Consistently high margins of approximately 35-40%

The Loyalty Penalty: Are Consumers Being Punished for Staying?

The CMA and regulators have, in recent years, identified the loyalty penalty and practices such as "Price Walking"1 as unfair.

September 24, 2021

Was the UK Vaccine Rollout Fair? A Closer Look at Access and Equity

Exclusive data gathered by Fideres suggests that NHS England’s Covid-19 vaccine rollout was indiscriminate. The AstraZeneca, Pfizer/BioNTech, and Moderna vaccines

August 24, 2021

An Epic Ruling With Long-Term Implications

As the antitrust legal community awaits with trepidation the decision in the Epic v. Apple1 landmark case, Fideres examines the

August 16, 2021

2020: A Review Of Key Antitrust Developments

As children across the country file and then refile an amended version of their Christmas list, their thoughts will naturally

August 13, 2021

Pandemic Profiteering? Scrutinizing COVID Travel Tests

Fideres’s research on PCR test prices has been featured in The Guardian. Of the top 50 cheapest PCR test providers,